Literature DB >> 22850733

Investigation of cortical glutamate-glutamine and γ-aminobutyric acid in obsessive-compulsive disorder by proton magnetic resonance spectroscopy.

Helen B Simpson1, Dikoma C Shungu, James Bender, Xiangling Mao, Xiaoyan Xu, Mark Slifstein, Lawrence S Kegeles.   

Abstract

Glutamatergic abnormalities in corticostriatal brain circuits are thought to underlie obsessive-compulsive disorder (OCD). Whether these abnormalities exist in adults with OCD is not clear. We used proton magnetic resonance spectroscopy (¹H MRS) to test our hypothesis that unmedicated adults with OCD have reduced glutamate plus glutamine (Glx) levels in the medial prefrontal cortex (MPFC) compared with healthy controls. Levels of γ-aminobutyric acid (GABA) were also explored. Twenty-four unmedicated adults with OCD and 22 matched healthy control subjects underwent ¹H MRS scans at 3.0 T. Resonances of both Glx and GABA were obtained using the standard J-editing technique and assessed as ratios relative to voxel tissue water (W) in the MPFC (the region of interest) and the dorsolateral prefrontal cortex (DLPFC) to explore the regional specificity of any finding. In the MPFC, Glx/W did not differ by diagnostic group (p=0.98) or sex (p=0.57). However, GABA/W was decreased in OCD (2.16±0.46 × 10⁻³) compared with healthy controls (2.43±0.45 × 10⁻³, p=0.045); moreover, age of OCD onset was inversely correlated with MPFC GABA/W (r=-0.50, p=0.015). MPFC GABA/W was higher in females than in males. In the DLPFC, there were no main effects of diagnosis or gender on Glx/W or GABA/W. These data indicate that unmedicated adults with OCD do not have Glx abnormalities in a MPFC voxel that includes the pregenual anterior cingulate cortex. However, they may have decreased MPFC GABA levels. How GABA abnormalities might contribute to corticostriatal dysfunction in OCD deserves further study.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22850733      PMCID: PMC3473334          DOI: 10.1038/npp.2012.132

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  46 in total

1.  Evidence for cortical inhibitory and excitatory dysfunction in obsessive compulsive disorder.

Authors:  Margaret A Richter; Danilo R de Jesus; Sylco Hoppenbrouwers; Melissa Daigle; Jasna Deluce; Lakshmi N Ravindran; Paul B Fitzgerald; Zafiris J Daskalakis
Journal:  Neuropsychopharmacology       Date:  2011-12-14       Impact factor: 7.853

2.  Altered cortical excitability in obsessive-compulsive disorder.

Authors:  B D Greenberg; U Ziemann; G Corá-Locatelli; A Harmon; D L Murphy; J C Keel; E M Wassermann
Journal:  Neurology       Date:  2000-01-11       Impact factor: 9.910

Review 3.  Neurobiology of obsessive-compulsive disorder: insights into neural circuitry dysfunction through mouse genetics.

Authors:  Jonathan T Ting; Guoping Feng
Journal:  Curr Opin Neurobiol       Date:  2011-05-24       Impact factor: 6.627

4.  Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy.

Authors:  Lawrence S Kegeles; Xiangling Mao; Arielle D Stanford; Ragy Girgis; Najate Ojeil; Xiaoyan Xu; Roberto Gil; Mark Slifstein; Anissa Abi-Dargham; Sarah H Lisanby; Dikoma C Shungu
Journal:  Arch Gen Psychiatry       Date:  2012-01-02

5.  Anterior cingulate cortex γ-aminobutyric acid in depressed adolescents: relationship to anhedonia.

Authors:  Vilma Gabbay; Xiangling Mao; Rachel G Klein; Benjamin A Ely; James S Babb; Aviva M Panzer; Carmen M Alonso; Dikoma C Shungu
Journal:  Arch Gen Psychiatry       Date:  2011-10-03

6.  Serotonin 2A receptors in obsessive-compulsive disorder: a positron emission tomography study with [11C]MDL 100907.

Authors:  Helen Blair Simpson; Mark Slifstein; James Bender; Xiaoyan Xu; Elizabeth Hackett; Michael J Maher; Anissa Abi-Dargham
Journal:  Biol Psychiatry       Date:  2011-11-01       Impact factor: 13.382

7.  Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy.

Authors:  G Sanacora; G F Mason; D L Rothman; K L Behar; F Hyder; O A Petroff; R M Berman; D S Charney; J H Krystal
Journal:  Arch Gen Psychiatry       Date:  1999-11

8.  Brief screening for family psychiatric history: the family history screen.

Authors:  M M Weissman; P Wickramaratne; P Adams; S Wolk; H Verdeli; M Olfson
Journal:  Arch Gen Psychiatry       Date:  2000-07

9.  Reproducibility of prefrontal γ-aminobutyric acid measurements with J-edited spectroscopy.

Authors:  Matthew Geramita; Jan Willem van der Veen; Alan S Barnett; Antonina A Savostyanova; Jun Shen; Daniel R Weinberger; Stefano Marenco
Journal:  NMR Biomed       Date:  2011-02-03       Impact factor: 4.044

Review 10.  The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder.

Authors:  Ke Wu; Gregory L Hanna; David R Rosenberg; Paul D Arnold
Journal:  Pharmacol Biochem Behav       Date:  2011-10-15       Impact factor: 3.533

View more
  32 in total

1.  Glutamate in Pediatric Obsessive-Compulsive Disorder and Response to Cognitive-Behavioral Therapy: Randomized Clinical Trial.

Authors:  Joseph O'Neill; John Piacentini; Susanna Chang; Ronald Ly; Tsz M Lai; Casey C Armstrong; Lindsey Bergman; Michelle Rozenman; Tara Peris; Allison Vreeland; Ross Mudgway; Jennifer G Levitt; Noriko Salamon; Stefan Posse; Gerhard S Hellemann; Jeffry R Alger; James T McCracken; Erika L Nurmi
Journal:  Neuropsychopharmacology       Date:  2017-04-04       Impact factor: 7.853

2.  An Examination of Rostral Anterior Cingulate Cortex Function and Neurochemistry in Obsessive-Compulsive Disorder.

Authors:  Brian P Brennan; Olga Tkachenko; Zachary J Schwab; Richard J Juelich; Erin M Ryan; Alison J Athey; Harrison G Pope; Michael A Jenike; Justin T Baker; William D S Killgore; James I Hudson; J Eric Jensen; Scott L Rauch
Journal:  Neuropsychopharmacology       Date:  2015-02-09       Impact factor: 7.853

Review 3.  GABAergic contributions to alcohol responsivity during adolescence: insights from preclinical and clinical studies.

Authors:  Marisa M Silveri
Journal:  Pharmacol Ther       Date:  2014-03-11       Impact factor: 12.310

4.  Dorsolateral prefrontal γ-aminobutyric acid in patients with treatment-resistant depression after transcranial magnetic stimulation measured with magnetic resonance spectroscopy

Authors:  Jennifer G. Levitt; Guldamla Kalender; Joseph O’Neill; Joel P. Diaz; Ian A. Cook; Nathaniel Ginder; David Krantz; Michael J. Minzenberg; Nikita Vince-Cruz; Lydia D. Nguyen; Jeffry R. Alger; Andrew F. Leuchter
Journal:  J Psychiatry Neurosci       Date:  2019-11-01       Impact factor: 6.186

5.  In vivo effects of ketamine on glutamate-glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder: Proof of concept.

Authors:  Carolyn I Rodriguez; Lawrence S Kegeles; Amanda Levinson; R Todd Ogden; Xiangling Mao; Matthew S Milak; Donna Vermes; Shan Xie; Liane Hunter; Pamela Flood; Holly Moore; Dikoma C Shungu; Helen B Simpson
Journal:  Psychiatry Res       Date:  2015-06-06       Impact factor: 3.222

Review 6.  Cortical and subcortical gamma amino acid butyric acid deficits in anxiety and stress disorders: Clinical implications.

Authors:  Andrew W Goddard
Journal:  World J Psychiatry       Date:  2016-03-22

7.  Effects of intensive cognitive-behavioral therapy on cingulate neurochemistry in obsessive-compulsive disorder.

Authors:  Joseph O'Neill; Eda Gorbis; Jamie D Feusner; Jenny C Yip; Susanna Chang; Karron M Maidment; Jennifer G Levitt; Noriko Salamon; John M Ringman; Sanjaya Saxena
Journal:  J Psychiatr Res       Date:  2013-01-04       Impact factor: 4.791

8.  Prefrontal cortical GABA transmission modulates discrimination and latent inhibition of conditioned fear: relevance for schizophrenia.

Authors:  Patrick T Piantadosi; Stan B Floresco
Journal:  Neuropsychopharmacology       Date:  2014-05-02       Impact factor: 7.853

9.  Frontal lobe γ-aminobutyric acid levels during adolescence: associations with impulsivity and response inhibition.

Authors:  Marisa M Silveri; Jennifer T Sneider; David J Crowley; Michael J Covell; Deepa Acharya; Isabelle M Rosso; J Eric Jensen
Journal:  Biol Psychiatry       Date:  2013-03-14       Impact factor: 13.382

10.  Altered activation in fronto-striatal circuits during sequential processing of conflict in unmedicated adults with obsessive-compulsive disorder.

Authors:  Rachel Marsh; Guillermo Horga; Nidhi Parashar; Zhishun Wang; Bradley S Peterson; H Blair Simpson
Journal:  Biol Psychiatry       Date:  2013-03-13       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.